{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:54:25Z","timestamp":1770728065338,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":661,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cmi.2022.02.020","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:44:14Z","timestamp":1645130654000},"page":"1023.e1-1023.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Variability of interferon-\u03b3 release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States"],"prefix":"10.1016","volume":"28","author":[{"given":"Kathryn","family":"Winglee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Belknap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason E.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy L.","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.02.020_bib1","series-title":"Reported tuberculosis in the United States, 2020","year":"2021"},{"key":"10.1016\/j.cmi.2022.02.020_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American thoracic society\/infectious diseases society of America\/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.02.020_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1183\/09031936.00117506","article-title":"Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay","volume":"29","author":"Leyten","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.02.020_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001850","article-title":"T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data","volume":"3","author":"Veerapathran","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.02.020_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"van Zyl-Smit","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.05058-11","article-title":"Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers","volume":"18","author":"Ringshausen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2022.02.020_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054748","article-title":"Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?","volume":"8","author":"Zwerling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.02.020_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1017\/ice.2015.19","article-title":"Interferon-gamma release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study","volume":"36","author":"Lucet","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2022.02.020_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1513\/AnnalsATS.201508-532OC","article-title":"Cumulative false-positive QuantiFERON-TB interferon-gamma release assay results","volume":"13","author":"Gamsky","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2022.02.020_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2022.02.020_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(21)00145-6","article-title":"Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study","volume":"22","author":"Ho","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2022.02.020_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2022.02.020_bib20","series-title":"A\u00a0language and environment for statistical computing","year":"2019"},{"key":"10.1016\/j.cmi.2022.02.020_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review","volume":"67","author":"Zwerling","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2022.02.020_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","author":"van Zyl-Smit","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.02.020_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-gamma) release Assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2022.02.020_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043790","article-title":"Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests","volume":"7","author":"Whitworth","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.02.020_bib25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00168-09","article-title":"Short-term reproducibility of a commercial interferon gamma release assay","volume":"16","author":"Detjen","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2022.02.020_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cyto.a.22317","article-title":"Flow-cytometric analysis of rare antigen-specific T cells","volume":"83","author":"Bacher","year":"2013","journal-title":"Cytometry A"},{"key":"10.1016\/j.cmi.2022.02.020_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.201706-1208OC","article-title":"Differential recognition of Mycobacterium tuberculosis-specific epitopes as a function of tuberculosis disease history","volume":"196","author":"Scriba","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.02.020_bib28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-TB Gold-Plus in health care workers in a low-incidence setting","volume":"55","author":"Moon","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.02.020_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.02.020_bib30","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1093\/cid\/ciaa1662","article-title":"Prevalence of latent tuberculosis infection among non-U.S.-born persons by country of birth\u2013United States, 2012\u20132017","volume":"73","author":"Collins","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.02.020_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5588\/ijtld.17.0650","article-title":"Paradox of serial interferon-gamma release assays: variability width more important than specificity size","volume":"22","author":"Stout","year":"2018","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:31:25Z","timestamp":1761118285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1198743X22000945"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.02.020","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variability of interferon-\u03b3 release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}